Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema.
Patients with hereditary angioneurotic edema (HANE) have serum levels of functionally active inhibitor of the first component of complement (C1 INH) between 5 and 30% of normal, instead of the 50% expected from the single normal allele. Increases in rates of catabolism have been documented in patien...
Tallennettuna:
| Julkaisussa: | J Clin Invest |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Clinical Investigation
1991
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295244/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1902490/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115175 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
